Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Angira

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|March 23, 2018
Good intentions do not replace ethical conduct in researchJoyce L Browne, Menno R Smit, Francis Angira, et al.
Plos One|August 3, 2016
Clinical Evaluation of the BD FACSPresto™ Near-Patient CD4 Counter in KenyaFrancis Angira, Benta Akoth, Paul Omolo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 25, 2021
Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)Douglas Shaffer, Johnstone Kumwenda, Huichao Chen, et al.
Pharmacogenetics and Genomics|August 9, 2021
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosisDavid W Haas, Rosie Mngqibisa, Jose Francis, et al.
The Open AIDS Journal|January 2, 2018
CD4 Lymphocyte Enumeration and Hemoglobin Assessment Aid for Priority Decisions: A Multisite Evaluation of the BD FACSPresto<sup>™</sup> SystemMadhuri Thakar, Francis Angira, Kovit Pattanapanyasat, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|March 23, 2018
Good intentions do not replace ethical conduct in researchJoyce L Browne, Menno R Smit, Francis Angira, et al.
Plos One|August 3, 2016
Clinical Evaluation of the BD FACSPresto™ Near-Patient CD4 Counter in KenyaFrancis Angira, Benta Akoth, Paul Omolo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 25, 2021
Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)Douglas Shaffer, Johnstone Kumwenda, Huichao Chen, et al.
Pharmacogenetics and Genomics|August 9, 2021
Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosisDavid W Haas, Rosie Mngqibisa, Jose Francis, et al.
The Open AIDS Journal|January 2, 2018
CD4 Lymphocyte Enumeration and Hemoglobin Assessment Aid for Priority Decisions: A Multisite Evaluation of the BD FACSPresto<sup>™</sup> SystemMadhuri Thakar, Francis Angira, Kovit Pattanapanyasat, et al.
Pageof 1